DRUG TRANSPORT IN THE KIDNEY - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 492

167. Mays DC, Dixon KF, Balboa A, Pawluk LJ, Bauer MR, Nawoot S, Gerber N. 1991. A non-
primate animal model applicable to zidovudine pharmacokinetics in humans: inhibition
of glucuronidation and renal excretion of zidovudine by probenecid in rats. J Pharmacol
Exp Ther 259:1261-1270.
168. Nozaki N, Kusuhara H, Endou H, Sugiyama Y. 2004. Quantitative evaluation of the drug-
drug interactions between methotrexate and nonsteroidal anti-inflammatory drugs in the
renal uptake process based on the contribution of organic anion transporters and reduced
folate carrier. J Pharmacol Exp Ther 309:226-234.
169. Uwai Y, Saito H, Hashimoto Y, Inui KI. 2000. Interaction and transport of thiazide
diuretics, loop diuretics, and acetazolamide via rat renal organic anion transporter rOAT1.
J Pharmacol Exp Ther 295:261-265.
170. Hasegawa M, Kusuhara H, Endou H, Sugiyama Y. 2003. Contribution of organic anion
transporters to the renal uptake of anionic compounds and nucleoside derivatives in rat.
J Pharmacol Exp Ther 305:1087-1097.
171. Mulato AS, Ho ES, Cihlar T. 2000. Nonsteroidal anti-inflammatory drugs efficiently
reduce the transport and cytotoxicity of adefovir mediated by the human renal organic
anion transporter 1. J Pharmacol Exp Ther 295:10-15.
172. Endou H. 1998. Recent advances in molecular mechanisms of nephrotoxicity, Toxicol
Lett 102-103:29-33.
173. Cihlar T, Lin DC, Pritchard JB, Fuller MD, Mendel DB, Sweet DH. 1999. The antiviral
nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal
organic anion transporter 1. Mol Pharmacol 56:570-580.
174. Ho ES, Lin DC, Mendel DB, Cihlar T. 2000. Cytotoxicity of antiviral nucleotides adefovir
and cidofovir is induced by the expression of human renal organic anion transporter 1.
J Am Soc Nephrol 11:383-393.
175. Lacy SA, Hitchcock MJ, Lee WA, Tellier P, Cundy KC. 1998. Effect of oral probenecid
coadministration on the chronic toxicity and pharmacokinetics of intravenous cidofovir
in cynomolgus monkeys. Toxicol Sci 44:97-106.
176. Pfohl-Leszkowicz A, Petkova-Bocharova T, Chernozemsky IN, Castegnaro M. 2002.
Balkan endemic nephropathy and associated urinary tract tumours: a review on aetiolog-
ical causes and the potential role of mycotoxins. Food Addit Contam 19:282-302.
177. Tsuda M, Sekine T, Takeda M, Cha SH, Kanai Y, Kimura M, Endou H. 1999. Transport
of ochratoxin A by renal multispecific organic anion transporter 1. J Pharmacol Exp Ther
289:1301-1305.
178. Deguchi T, Ohtsuki S, Otagiri M, Takanaga H, Asaba H, Mori S, Terasaki T. 2002. Major
role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney. Kidney
Int 61:1760-1768.
179. Motojima M, Hosokawa A, Yamato H, Muraki T, Yoshioka T. 2002. Uraemic toxins
induce proximal tubular injury via organic anion transporter 1-mediated uptake. Br J
Pharmacol 135:555-563.
180. Enomoto A, Takeda M, Tojo A, Sekine T, Cha SH, Khamdang S, Takayama F, Aoyama
I, Nakamura S, Endou H, Niwa T. 2002. Role of organic anion transporters in the tubular
transport of indoxyl sulfate and the induction of its nephrotoxicity. J Am Soc Nephrol
13:1711-1720.
181. Deguchi T, Kusuhara H, Takadate A, Endou H, Otagiri M, Sugiyama Y. 2004. Charac-
terization of uremic toxin transport by organic anion transporters in the kidney. Kidney
Int 65:162-174.